Fritextsökning
Innehållstyper
-
Kombinationsstudie med simeprevir visar positiva resultat
Medivirs hepatit C-läkemedel simeprevir har genomgått en lyckad fas IIa-studie ihop med BMS dito. Men fler studier krävs för att ge en helhetsbedömning.
-
Presenterar data från två kliniska studier
Sobi och partnern Biogen visar upp nya resultat på kongress i Kanada.
-
Hon tar över EU-support
Tuulikki Lindmark är ny på posten.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Medicon Valley cluster in brief
The Medicon Valley covers the Öresund region (Skåne and Sjaelland).
-
An industry emerging from crisis
"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "
-
We are poor lobbyists
I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.
-
From planning stage to handshake
"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...
-
Amerikaner investerar mer i biotech
Satsade 22,9 miljarder kronor under 2011.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Proteinrening innesluten i ett och samma rör
Amicon Pro från Emd Millipore möjliggör proteinrening i en och samma behållare vilket minimerar svinnet under reningsprocessen.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Life science management for hire
Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...
-
"Kan döda 10 miljoner varje år"
Om ingenting görs mot antibiotikaresistensen så kan resistenta bakterier döda en person var tredje sekund världen över år 2050. Det menar en ny rapport som pres...
-
A platform for dialogue
As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...
-
Stort intresse för Lund
50 uppstartsbolag från hela världen sökte när det var dags för den andra upplagan av e-hälsoacceleratorn Health2B. Nio bolag valdes ut.
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Länder enas mot resistensen
Igår onsdag anordnade FN en generalförsamling om det växande hotet med antibiotikaresistens och om hur medlemsländerna kan samarbeta mot problemet.
-
New Nordic biotech company
The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Diagnostics to deal with new diseases
Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...